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Abstract
The slow delayed-rectifier potassium current (IKs) is crucial for human cardiac action poten-
tial repolarization. The formation of IKs requires co-assembly of the KCNQ1 α-subunit and
KCNE1 β-subunit, and mutations in either of these subunits can lead to hereditary long QT
syndrome types 1 and 5, respectively. It is widely recognised that the KCNQ1/KCNE1 (Q1/
E1) channel requires phosphatidylinositol-4,5-bisphosphate (PIP2) binding for function. We
previously identified a cluster of basic residues in the proximal C-terminus of KCNQ1 that
form a PIP2/phosphoinositide binding site. Upon charge neutralisation of these residues we
found that the channel became more retained in the endoplasmic reticulum, which raised
the possibility that channel–phosphoinositide interactions could play a role in channel traf-
ficking. To explore this further we used a chemically induced dimerization (CID) system to
selectively deplete PIP2 and/or phosphatidylinositol-4-phosphate (PI(4)P) at the plasma
membrane (PM) or Golgi, and we subsequently monitored the effects on both channel traf-
ficking and function. The depletion of PIP2 and/or PI(4)P at either the PM or Golgi did not
alter channel cell-surface expression levels. However, channel function was extremely sen-
sitive to the depletion of PIP2 at the PM, which is in contrast to the response of other cardiac
potassium channels tested (Kir2.1 and Kv11.1). Surprisingly, when using the CID system
IKs was dramatically reduced even before dimerization was induced, highlighting limitations
regarding the utility of this system when studying processes highly sensitive to PIP2 deple-
tion. In conclusion, we identify that the Q1/E1 channel does not require PIP2 or PI(4)P for
anterograde trafficking, but is heavily reliant on PIP2 for channel function once at the PM.
Introduction
Cardiac repolarisation is determined by a number of K+ currents, including the slow delayed-
rectifier potassium current (IKs), the rapid delayed-rectifier potassium current (IKr) and the
inward-rectifier potassium current (IK1). The channel underlying IKs is a heteromultimeric
complex comprised of a canonical voltage-gated K+ channel α-subunit, KCNQ1 (Q1) (Kv7.1),
and a β-subunit, KCNE1 (E1) [1, 2]. In a related vein, the Kv11.1 α-subunit forms the human
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ether-a-go-go-related gene (hERG) channel and constitutes the IKr current in human ventricu-
lar myocytes [3]. IK1 is a classic inward rectifier K+ current and is likely constituted predomi-
nantly by Kir2.1 [4].
IKs is so named because of its slow kinetics, which allow the current to accumulate at high
heart rates. Notably, IKs is augmented through increased adrenergic drive [5–7]. As such, IKs is
thought to be particularly important during exercise, when it plays a major role in action
potential and QT interval shortening [8]. This is supported by the fact that most cases of sud-
den death in patients with long QT syndrome type 1 (LQT1; caused by mutations in Q1) occur
during exercise [9].
Numerous ion channels are regulated by phosphatidylinositols [10–12]. Phosphatidylinosi-
tols are a family of acidic phospholipids, each member differing in the phosphorylation of its
myo-inositol ring. These phospholipids are present on the cytosolic face of cellular membranes
and are involved in many biological processes, including vesicle formation and trafficking
[13]. Phosphatidylinositol (PI) is synthesised in the endoplasmic reticulum (ER) and is subse-
quently transported via specific transfer proteins or vesicles. PI kinases then phosphorylate PI
to generate different PI species in the relevant cellular location. For example, phosphatidylino-
sitol-4,5-bisphosphate (PIP2 or PI(4,5)P2) is predominantly present in the plasma membrane
(PM), whilst phosphatidylinositol-4-phosphate (PI(4)P) is present in the PM but is also
enriched at the Golgi [13, 14].
It is well established that the Q1/E1 channel requires the presence of PIP2 to function, and
it is thought that it acts to stabilise the channel in an open state [15–17]. Other KCNQ channels
also require PIP2 for voltage-dependent activation, and PIP2 depletion is likely the main mech-
anism by which the muscarinic acetylcholine receptor (M1) induces M-channel (KCNQ2/3)
closure [15, 18]. In our earlier work we defined a PIP2-binding region in the proximal C-termi-
nus of the channel, with the most important residues in this region being Lys358 and Arg360
[19]. Even though PIP2 bound to the channel with the highest affinity, other phosphoinositide
species could also bind [19]. Furthermore, we showed that the homologous residues in
KCNQ2/3 are also likely to form a phosphoinositide binding site [20, 21]. In a recent structural
study of KCNQ1 using cryo-electron microscopy, the voltage sensor domains were uncoupled
from the closed pore region in the absence of PIP2 [22]. Therefore, it is clear that PIP2, through
direct binding to a KCNQ potassium channel domain, can modulate channel opening [23, 24].
What is less clear, however, is whether binding of PIP2 in the PM and/or PI(4)P in the Golgi
plays a role in the anterograde trafficking of KCNQ channels. This is a relevant issue for
KCNQ1 as a number of LQT1-causing mutations reside in PIP2 binding sites [25], and we
have shown that the impaired delivery of mutant channels to the PM and their retention in the
ER is an important disease mechanism [26, 27].
The established methods for assessing the function of phosphoinositides, such as activation
of a Gq/11-coupled G-protein coupled receptor (GPCR) or the addition of wortmannin, tend to
be indirect and lack specificity. For example, the kinase inhibitory actions of wortmannin are
wider ranging than previously thought [28] and the phospholipase C (PLC)-mediated deple-
tion of PIP2 upon activation of the M1 receptor (a Gq/11-GPCR) additionally produces diacyl-
glycerol, activates protein kinase C and mobilises Ca2+ from intracellular stores. The
identification of the voltage-sensitive phosphatase (VSP) from Ciona intestinalis (Ci-VSP) [29]
has provided a tool that can deplete PIP2 in a more specific manner. Ci-VSP localises to the
PM and can rapidly deplete PIP2 and phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P3)
upon membrane depolarization [30]. VSPs, in conjunction with patch clamp recording, have
been used to determine the PIP2 dependence of a range of ion channels (for example [31] and
[32]). However, despite the obvious advantages of VSPs their PM localisation and requirement
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for membrane depolarisation can be limiting (for example when trying to study cellular pro-
cesses such as signaling and protein trafficking).
In 2006, a novel chemically induced dimerization (CID) system was developed to enable
the selective depletion PIP2 at the PM without activating PLC or other downstream pathways
[33]. This CID system exploits the ability of two protein domains, one from FK506 binding
protein (FKBP) and one from mTOR (mechanistic target of rapamycin) FKBP-rapamycin
binding (FRB) to heterodimerize upon the addition of rapamycin or a chemical analog iRap
(for review see [34]). By fusing the yeast inositol phosphatase (Inp54p) to FKBP (Inp54p-
FKBP) and the FRB domain to a PM anchor Lyn11 (Lyn11-FRB), Suh and colleagues were able
to rapidly recruit and concentrate Inp54p at the PM upon the addition of iRap [33]. Using this
CID system the authors elegantly identified that the depletion of PIP2 alone, upon recruitment
of Inp54p-FKBP to the PM, is sufficient to result in M-channel closure [33].
Similar CID approaches have since been used to examine a variety of biological processes
and they provide an exciting tool for studying signaling pathways [35]. In this study, we use a
CID system [36] to examine whether PIP2 and/or PI(4)P play a role in the anterograde traffick-
ing and function of the Q1/E1 channel complex that underlies IKs.
Materials and methods
Chemically induced dimerization (CID) system and other constructs
Constructs that were tethered to cell membranes were linked to the FRB domain. LYN11-FRB
constructs are tethered to the PM by a LYN11 sequence (GCIKSKGKDSA): Untagged LYN11-
FRB (LYN11-targeted-FRB) (20147, Addgene; deposited by Professor Tobias Meyer), LYN11-
FRB-CFP (38003, Addgene) and LYN11-FRB-mCherry (38004, Addgene; both deposited by
Professor Robin Irvine) [36]. Tgn38-FRB and Tgn38-FRB-CFP are tethered to the trans-Golgi
network by the integral trans-Golgi network protein Tgn38 (a gift from Professor Tamas Balla,
National Institute of Child Health and Human Development, National Institutes of Health,
Bethesda, United States) [37].
FKBP-containing constructs were those that included phosphatase domains: Pseudojanin
(PJ) (37999), PJ-SAC (38000), PJ-INPP5E (38001) and PJ-DEAD (38002) (all from Addgene;
all deposited by Professor Robin Irvine) [36]. Each of these constructs consists of a red fluores-
cent protein (RFP) domain, SAC1 domain, INPP5E domain and an FKBP domain. The SAC1
domain of these constructs encodes the SAC1 phosphatidyl phosphatase, which dephosphory-
lates phosphatidylinositols at the 4-position, but has no activity against PIP2. The INPP5E
domain encodes an inositol 1,4,5-trisphosphate (IP3) 5-phosphatase, which dephosphorylates
PIP2 on the 5-position. In PJ both phosphatase domains are active, whilst PJ-SAC contains
an inactivating mutation (Asp1263Ala) in the INPP5E domain and PJ-INPP5E contains an
inactivating mutation (Cys779Ser) in the SAC1 domain. Therefore, PJ-SAC dephosphorylates
only PI(4)P at the 4-position, and PJ-INPP5E dephosphorylates only PIP2 at the 5-position.
PJ-DEAD contains both inactivating mutations (Asp1263Ala and Cys779Ser). Hence,
PJ-DEAD is used as a control construct [36].
The VSV-KCNE1-KCNQ1 (VSV-E1-Q1) construct (a gift from Dr Jean Me´rot (Institut du
Thorax, Universite´ de Nantes, France)) consists of the VSV epitope fused to the extracellular
(N-terminal) side of KCNE1. The C-terminal end of KCNE1 is fused to the N-terminal end of
KCNQ1 [38, 39]. The VSV epitope is used for detecting the cell-surface expression of the
KCNQ1-KCNE1 channel complex [39]. Human KCNJ2 (Kir2.1) was a gift from Professor
Yoshihiro Kubo [40]. Human KCNH2 isoform A (Kv11.1/hERG1a) was a gift from Professor
Asipu Sivaprasadarao (University of Leeds, U.K.). KCNQ1, KCNQ1-GFP, KCNQ1 Glu261Asp
mutant (KCNQ1-E261D), KCNE1 and DsRed2-ER are as described in [26]. Tubby-YFP was
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used as previously described [41]. The SAR1 His79Gly mutant (SAR1-H79G) was a gift from
Professor Philip Wedegaertner (Thomas Jefferson University, Philadelphia, USA) [42].
Cell culture and cell lines
Human Embryonic Kidney-293 (HEK293) cells were a gift from Professor Lily Jan (Howard
Hughes Medical Institute, San Francisco, USA). Chinese Hamster Ovary-K1 (CHO-K1) cells
were purchased from the European Collection of Authenticated Cell Cultures (supplied by
Sigma (85051005)). Both cell lines were cultured as previously described [26, 43]. Fugene HD
(E2311, Promega) and Lipofectamine 2000 (11668019, Thermo Fisher Scientific) were used
for transient transfection of cells according to the manufacturer’s instructions. Stable HEK293
cell lines expressing KCNH2 (Kv11.1; hERG1a; HEK-IKr), KCNJ2 (Kir2.1; HEK-IK1) and
KCNQ1-GFP/KCNE1 (HEK-IKs) were generated using previously described approaches [44].
In-cell/on-cell western assays
24-well plates (CELLSTAR, Greiner Bio-One Ltd) were coated with poly-L-lysine (P4707,
Sigma Aldrich) before HEK293 cells were seeded at 30% confluence. After 2 days, cells were
transfected using Lipofectamine 2000. Cells were transfected with a total of 2 μg cDNA per
well. In each well, 1 μg VSV-E1-Q1 was used, and the remaining 1 μg was either SAR1-H79G,
KCNQ1-E261D or a combination of 500 ng PJ/PJ-SAC/PJ-DEAD and 500 ng LYN11-FRB/
Tgn38-FRB. For control wells, and those destined for the addition of wortmannin (1232,
Tocris Bioscience) or brefeldin A (B7651, Sigma Aldrich), 1 μg pcDNA3.1 (empty vector) was
co-transfected with VSV-E1-Q1.
For the in-cell western assay, cells were washed with PBS+ (PBS supplemented with 1 mM
MgCl2 & 0.1 mM CaCl2) then fixed using 3.7% formaldehyde solution (PBS
+ + formaldehyde)
for 20 minutes. After fixing, cells were washed with PBS+, and then permeabilized with 0.1%
triton-X100 solution (PBS+ + triton-X100). Cells were washed with PBS+ and incubated in cell
culture media for 30 minutes. Primary antibody (Ab) was added (α-KCNQ1; sc-20816, Santa
Cruz) in 200 μl cell culture media/well at a 1:1000 dilution, and the cells incubated on a rock-
ing platform at room temperature for 1 hour. Cells were washed with PBS+ before adding sec-
ondary Ab (α-Rabbit Dylight 800; 5151S, New England Biolabs) in 500 μl cell culture media/
well at a 1:1000 dilution. During secondary Ab incubation, cells were protected from light and
incubated on a rocking platform at room temperature for 1 hour. Cells were then washed 3
times with PBS+, and 500 μl PBS+ was added to each well for visualisation.
For the on-cell western assay, cells were either incubated in humidified cell culture incuba-
tor at 37˚C throughout the assay [37˚C live] or were fixed after a 1-hour incubation with the
primary Ab at 4˚C [4˚C fixed] as indicated in the figure legends. 37˚C live assay: Primary Ab
(α-VSV; V5507, Sigma) was added in 200 μl cell culture media at a 1:500 dilution for 1 hour at
37˚C. Cells were then washed three times for 10 mins in cell culture media. Secondary Ab was
then added (α-mouse DyLight800, 5257S, New England Biolabs) in 500 μl cell culture media at
a 1:1000 dilution for 1 hour. Cells were washed twice with PBS+, and 500 μl PBS+ was added to
each well for visualisation. 4˚C fixed assay: Primary Ab (α-VSV) was added in 200 μl ice-cold
cell culture media at a 1:500 dilution for 1 hour at 4˚C. Cells were then washed once in ice-
cold cell culture media and twice in ice-cold PBS+. Cells were then fixed using 3.7% formalde-
hyde for 20 minutes. After fixing, cells were washed with PBS+, and secondary Ab was added
(α-mouse DyLight800) in 500 μl cell culture media at a 1:1000 dilution for 1 hour at RT. Cells
were washed twice with PBS+, and 500 μl PBS+ was added to each well for visualisation.
Plates were visualised using a LI-COR Odyssey Plate Reader. To correct for any background
signal not related to specific channel staining, the mean intensity of the wells that were
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untransfected was subtracted from the intensity of the wells expressing the channel. To nor-
malise the infrared signals between assays, the mean intensity values from the various transfec-
tion conditions were normalised to the mean intensity values from the cells transfected with
VSV-E1-Q1 + pcDNA3.1.
Rapamycin (5 μM) (sc-3504, Santa Cruz) was added, either 1 hour or 24 hours before the
start of the assay. Wortmannin (10 μM) was added 1 hour prior to the start of the assay, and
brefeldin A (5 μM) was added 24 hours before starting the assay.
Electrophysiology
Whole-cell patch clamp was used to record ionic currents at room temperature using an Axo-
patch 200B amplifier (Axon Instruments). Transiently transfected cells (500 ng per construct)
were identified using epifluorescence and were patch clamped 48–72 hours after transfection.
Extracellular bath solution for all experiments with HEK-IKs, HEK-IK1 and CHO-K1 cells con-
tained (mM) 150 NaCl, 5 KCl, 10 HEPES, 2 MgCl2 and 1 CaCl2 (pH 7.4 with NaOH). Extracel-
lular bath solution for all experiments with HEK-IKr cells contained (mM) 150 NaCl, 4 KCl, 10
HEPES, 1 MgCl2, 1.8 CaCl2 and 5 glucose (pH 7.4 with NaOH). The intracellular pipette solu-
tion contained (mM) 150 KCl, 10 HEPES, 5 EGTA, 2 MgCl2, 1 CaCl2 and 5 (Na)2ATP (pH 7.2
with KOH). Pipette resistance, when pipettes were filled with intracellular solution, was 2–3
MO. Pipette tips were coated with SigmaCote (SL2, Sigma) after being filled with intracellular
solution, to reduce pipette capacitance. After seal formation and successful rupture of the
membrane patch, cells were dialysed for 2 minutes before recording. In all experiments, Rseries
was compensated for by 70% using the amplifier circuitry. The voltage protocols used are indi-
cated in each figure. The liquid junction potentials for both combinations of solutions were
relatively small (+4.3 and +4.4 mV respectively) and therefore post-recording adjustments of
membrane potential were not performed. In experiments involving the perfusion of rapamy-
cin, extracellular solution containing rapamycin (5 μM) was perfused for 2 minutes, after
which perfusion was then returned to rapamycin-free extracellular solution.
Data were analysed using Clampfit (Molecular Devices, CA, U.S.A) and GraphPad Prism
(GraphPad Software, Inc., San Diego, CA, U.S.A). Current density (CD) was calculated by nor-
malising the peak current value at the end of each activating pulse to the cell capacitance (nA/
pF). Peak tail current density (PTCD) was calculated by normalising the peak tail current
value at the start of the repolarising pulse to cell capacitance (pA/pF).
Confocal microscopy
Live cells transiently transfected with 500 ng of each construct were imaged 48–72 hours after
transfection using a Zeiss LSM510 confocal microscope (Mark 4; Carl Zeiss, Oberkochen, Ger-
many) and a Plan-Apochromat 63x oil lens objective. GFP was excited with a multiline argon
laser (wavelength 488 nm) and RFP was excited using a helium/neon laser (wavelength 543
nm). Tubby-YFP was imaged using laser settings and filters optimal for excitation of GFP in
order to reduce potential cross-talk with RFP. GFP/YFP and RFP/DsRed were excited sequen-
tially to minimise potential crosstalk. Images were median-filtered, converted to RGB format
and saved in a JPEG/TIFF format. Colocalisation analysis was performed as described in [45].
Statistical analysis
Data are expressed as mean ± S.E.M. Statistical analysis was performed using GraphPad Prism.
A Student’s t-test (P<0.05) was used to determine statistical significance for single compari-
sons, and a one-way ANOVA (P<0.05), with Bonferroni’s multiple comparison test, was used
to determine significance when multiple groups were compared.
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Results
Mutations in a PIP2 binding domain in KCNQ1 lead to increased
retention of the channel complex in the ER
We previously identified charged residues in the proximal C-terminus of KCNQ1 important
for phosphoinositide binding [19]. Subsequently, we examined whether the mutation of these
residues in KCNQ1-GFP (co-transfected with KCNE1) affected channel trafficking and reten-
tion in the ER in transiently transfected CHO-K1 cells. We found that these mutants displayed
greater ER retention than the wild-type (WT) channel (Fig 1). This raised the question of
whether anionic phospholipid binding was important for the trafficking of KCNQ1 in the
secretory pathway. To explore this in a more definitive manner we employed a CID system,
described in the materials and methods section, specifically to examine the roles played by
PIP2 and PI(4)P in Q1/E1 channel trafficking and function.
Characterisation of the CID system using a specific PIP2 reporter
Previously we developed a specific fluorescent probe that is able to monitor and report changes
in PIP2 levels at the PM, named Tubby-YFP [41]. Using Tubby-YFP we monitored whether
the CID system was working as expected. PJ-DEAD or PJ were transiently expressed with
LYN11-FRB and Tubby-YFP in HEK293 cells, and imaged using confocal microscopy. When
rapamycin (5 μM) was added to cells expressing PJ-DEAD or PJ with LYN11-FRB and Tubby-
YFP, both PJ-DEAD and PJ translocated from the cytosol/nucleus to the PM in 30–45 seconds
(Fig 2A and 2B). In cells expressing PJ, Tubby-YFP underwent a rapid redistribution after the
translocation of PJ to the PM (Fig 2A, 2C and 2D). At 45 seconds after rapamycin addition,
Tubby-YFP had partially moved from the PM to the cytosol, and at 60 seconds it showed a
complete redistribution (Fig 2A, 2C and 2D). In contrast, in cells expressing PJ-DEAD there
was no movement of Tubby-YFP after translocation of PJ-DEAD to the PM (Fig 2B, 2E and
2F). The redistribution of Tubby-YFP from the PM to the cytosol when PJ, but not PJ-DEAD,
was recruited to the PM indicates that the CID system was working as expected.
PIP2/PI(4)P modulation of IK1 and IKr channel function
We next examined the effects of CID-system-mediated depletion of PIP2 and PI(4)P at the PM
on the cloned equivalents of cardiac currents IK1 and IKr in HEK293 cell lines stably expressing
hKir2.1 (KCNJ2) and Kv11.1 (KCNH2; hERG1a), respectively. In the recording conditions
used, the currents were stable for ~10 minutes and did not run down (Fig 3A and 3C). The
expression of any combination of the CID constructs prior to the addition of rapamycin did
not act to significantly suppress either of the currents (S1 Fig and Fig 3B and 3D). Rapamycin
(5 μM) was perfused over HEK-IK1 cells expressing PJ-DEAD and LYN11-FRB for 2 minutes
after the completion of the first I-V recording. The inward rectifier current was recorded every
minute for 8 minutes. Over this period, there was no change in peak inward current density
(CD) (P = NS) (Fig 3B). The same experiment was repeated in HEK-IK1 cells expressing
PJ-INPP5E and LYN11-FRB, and after 8 minutes there was no change in the peak inward CD
(P = NS) (Fig 3B). Finally, rapamycin was added to cells expressing PJ and LYN11-FRB. After
rapamycin (5 μM) perfusion for 2 minutes there was a gradual but complete inhibition of the
peak inward IK1 CD over approximately 6 minutes (P<0.05 at +1 min rapamycin, and P
<0.005 at +2 minutes rapamycin onwards), with only endogenous HEK293 current remaining
from 6 minutes (Fig 3B). This current was significantly reduced compared to control (P
<0.001 across all time points analysed) and PJ-DEAD (P<0.001 across all time points
analysed).
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Fig 1. Charge-neutralising mutations in a PIP2-binding region in the proximal C-terminus of KCNQ1 increase retention of the
channel complex in the ER. A. Representative confocal images of the localisation of WT and mutant KCNQ1-GFP channel complexes in
CHO-K1 cells. The left panel shows the GFP-tagged KCNQ1 subunit (GFP), the middle panel shows DsRed2-ER, an ER marker, and the
right panel shows the merged images. In the merged image panel, the presence of yellow indicates colocalisation between KCNQ1-GFP
and DsRed2-ER. Top row: WT KCNQ1-GFP with KCNE1. Lower rows: Localisation of the mutant KCNQ1 channels investigated (all n = 25,
except KCNQ1(R360A-GFP), where n = 24). Scale bar indicates 20 μm. B. Quantified data showing the proportion of ER colocalisation of
the WT and mutant KCNQ1-GFP subunits (in all cases KCNE1 was co-expressed). Data are presented as mean ± S.E.M. * indicates
significant difference (P <0.05) from control (KCNQ1-GFP + KCNE1) value.
https://doi.org/10.1371/journal.pone.0186293.g001
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In an analogous fashion we examined the effects on IKr. Rapamycin (5 μM) was perfused
over HEK-IKr cells expressing PJ-DEAD and LYN11-FRB for 2 minutes after completion of the
first I-V recording. Over a period of 10 minutes, there was a small reduction in peak tail cur-
rent density (PTCD), which was not significant (P = NS) and was similar to untransfected cells
(Fig 3D). When rapamycin was perfused over HEK-IKr cells expressing PJ and LYN11-FRB for
2 minutes, there was a small inhibition of the PTCD (Fig 3D) beyond that seen in untrans-
fected HEK-IKr cells and cells expressing PJ-DEAD and LYN11-FRB, but this difference was
not significant (P = NS). These results highlight that IK1 is significantly inhibited by dual PIP2/
PI(4)P depletion whilst IKr is not.
Fig 2. The localisation of the PIP2 sensor, Tubby-YFP, in HEK293 cells before and after the rapamycin-
induced recruitment of PJ or PJ-DEAD to the PM. The rapamycin (Rap)-induced dimerization of PJ and
PJ-DEAD with PM-localised LYN11-FRB was investigated in transiently transfected HEK293 cells. Tubby-
YFP localises to the PM in the presence of a sufficient PIP2 concentration. A and B. Top panel: Before
rapamycin addition. Lower panels: Increasing time after addition of rapamycin showing the increased PM
signal of PJ and PJ-DEAD. Upon recruitment of PJ to the PM, Tubby-YFP redistributes from the PM to the
cytosol (A). Upon recruitment of PJ-DEAD to the PM, Tubby-YFP remains PM-localised (B). Scale bar
indicates 15 μm. C–F. Quantified line (C and E) and box plots (D and F) from the indicated red lines and boxed
areas in A and B (located in the top right hand merged panels), highlighting translocation of Tubby-YFP to the
cytosol when PJ (C and D) but not PJ-DEAD (E and F) is recruited to the PM. Red arrows indicate rapamycin
addition.
https://doi.org/10.1371/journal.pone.0186293.g002
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Fig 3. Rapamycin-induced recruitment of lipid-depleting constructs reduces IK1 but not IKr. A. Representative
whole-cell current traces (t = 0 and 6 minutes), CD (t = 0 and 10 minutes) and relative current (at -150 mV) (normalised
to 0 minutes) from HEK-IK1 cells. B. Representative current traces and relative current (at -150 mV) (normalised to 0
minutes) from HEK-IK1 cells expressing PJ, PJ-DEAD or PJ-INPP5E with LYN11-FRB, before and 6 minutes after
rapamycin (5 μM) perfusion (orange bar). PJ (n = 9), PJ-DEAD (n = 9) or PJ-INPP5E (n = 11). Relative CD from
untransfected HEK-IK1 cells (at -150 mV) (control; n = 11) is included for comparison. C. Representative current traces
and PTCD from HEK-IKr cells recorded at t = 0 and 10 minutes. D. Representative current traces and relative current (at
0 mV) (normalised to 0 mins) from HEK-IKr cells expressing PJ or PJ-DEAD with LYN11-FRB, before and 10 minutes
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PIP2/PI(4)P depletion strongly modulates Q1/E1 channel function
Expression of PJ-DEAD and LYN11-FRB had no effect on IKs CD or PTCD in HEK-IKs cells
compared to control (untransfected) cells (Fig 4A, 4B and 4C). Next, PJ-SAC, PJ-INPP5E or
PJ were transiently expressed with LYN11-FRB in HEK-IKs cells, and IKs was recorded in each
condition. Expression of PJ-SAC with LYN11-FRB had no effect on IKs CD or PTCD (P = NS),
while expression of PJ-INPP5E with LYN11-FRB resulted in a reduction of IKs CD and PTCD
by approximately 50% compared to control (P<0.005 across all voltages analysed for both CD
and PTCD) (Fig 4A, 4B and 4C). PJ-INPP5E also significantly reduced IKs compared to
PJ-DEAD (P<0.001 across all voltages analysed for both CD and PTCD) (Fig 4A, 4B and 4C).
Expression of PJ with LYN11-FRB in HEK-IKs cells caused a near complete loss of IKs in the
absence of rapamycin application (P<0.001 across all voltages analysed for CD and PTCD
when compared to control or PJ-DEAD) (Fig 4A, 4B and 4C).
Due to the near complete loss of IKs that was observed in HEK-IKs cells expressing PJ with
LYN11-FRB, a similar experiment was performed in CHO-K1 cells to rule out cell-type-specific
effects. The IKs channel subunits, KCNQ1 and KCNE1, were expressed in CHO-K1 cells with
LYN11-FRB and PJ-DEAD, and the resulting current was recorded. While expressing
PJ-DEAD, IKs current was detected. However, the expression of PJ in place of PJ-DEAD
caused a dramatic loss of the current as previously seen in HEK-IKs cells, which was signifi-
cantly reduced (P<0.0001) across all voltages analysed for both CD and PTCD (S2 Fig). A
similar suppression of KCNQ1 (Kv7.1) currents occurred if KCNQ1 was expressed in the
absence of KCNE1 in CHO-K1 cells (S3 Fig). In addition, when PJ was expressed alone (with-
out LYN11-FRB) in HEK-IKs cells there was a substantial, albeit less prominent, reduction
(~50%) in current (Fig 4D and 4E).
The depletion of PIP2 and/or PI(4)P at the PM and PI(4)P in the Golgi
does not affect the cell surface expression level of KCNQ1
We used in-cell and on-cell western assays to measure the surface expression and trafficking of
VSV-E1-Q1. When HEK293 cells transiently expressing VSV-E1-Q1 were incubated for 1
hour with wortmannin (10 μM), which inhibits both phosphatidylinositol 4-kinase (PI4K)
and 3-kinase (PI3K) activity at this concentration [46], there was no change in the total
VSV-E1-Q1 channel expression. Wortmannin incubation did, however, cause a significant
reduction in cell-surface expression of the VSV-E1-Q1 construct (P<0.01) (Fig 5). Incubation
of VSV-E1-Q1-expressing HEK293 cells with brefeldin A (5 μM) for 24 hours resulted in some
cell death. The total cellular expression of VSV-E1-Q1 was significantly reduced (P<0.001)
after 24 hours brefeldin A incubation, but it is unclear whether this was solely due to the reduc-
tion in total cell number or whether there was an actual reduction in VSV-E1-Q1 protein
expression (Fig 5D). Brefeldin A incubation also dramatically reduced the cell-surface expres-
sion of the VSV-E1-Q1 construct (P<0.001) (Fig 5C).
In addition, the assay was able to report genetically encoded perturbations that might affect
channel trafficking. We have previously shown that the KCNQ1 mutant, KCNQ1-E261D, is
retained in the ER and that this behaviour is dominant, i.e. co-expression with WT leads to
retention of both mutant and WT [26]. Overexpression of KCNQ1-E261D led to reduction in
after rapamycin (5 μM) perfusion (orange bar). PJ-DEAD (n = 10) or PJ (n = 10). Relative current (at 0 mV) from
untransfected HEK-IKr cells (control; n = 9) included for comparison. Data are presented as mean ± S.E.M. * indicates
significant difference (P <0.05) from control value.
https://doi.org/10.1371/journal.pone.0186293.g003
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Fig 4. The expression of lipid-depleting dimerization constructs dramatically reduces IKs prior to
rapamycin addition. A. Representative traces of currents recorded from HEK-IKs cells (control), and HEK-IKs
cells transiently expressing PJ-DEAD, PJ-SAC, PJ-INPP5E or PJ with LYN11-FRB. Mean CD (B) and PTCD
(C) of currents from HEK-IKs cells transiently expressing PJ (n = 11), PJ-SAC (n = 23), PJ-INPP5E (n = 24) or
PJ-DEAD (n = 16) with LYN11-FRB. D. Representative traces of the effect of PJ expression alone (without
LYN11-FRB) on IKs in HEK-IKs cells. E. Effect of PJ expression alone (without LYN11-FRB) on IKs PTCD in
HEK-IKs cells (PJ-expressing cells, n = 12; control (untransfected cells), n = 12). Data are presented as
mean ± S.E.M. * indicates significant difference (P <0.05) from control (untransfected cells) value.
https://doi.org/10.1371/journal.pone.0186293.g004
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Fig 5. Measuring and manipulating the cell-surface and total expression level of KCNQ1. A and B. Representative on-cell [37˚C
live] and in-cell western assays, enabling quantification of the cell-surface and total channel expression of the VSV-KCNE1-KCNQ1
(VSV-E1-Q1) channel, respectively. The VSV-E1-Q1 construct was co-expressed in HEK293 cells with either pcDNA3.1, SAR1-H79G or
KCNQ1-E261D. Cells expressing VSV-E1-Q1 with pcDNA3.1 were incubated with either 10 μM wortmannin (WTM) for 1 hour or 5 μM
brefeldin A (Brf A) for 24 hours before the start of the assay. Each condition was performed in triplicate. Mean data, normalised to
VSV-E1-Q1 + pcDNA3.1 values (VSV Control), from three independent experiments for cell-surface and total channel expression are
shown in C and D, respectively. Data presented as mean ± S.E.M. * indicates significant difference (P <0.05) from control (VSV-E1-Q1
+ pcDNA3.1) value.
https://doi.org/10.1371/journal.pone.0186293.g005
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cell-surface but not total expression (Fig 5). Furthermore, expression of SAR1-H79G, which
disrupts ER export, also decreased cell surface but not total expression (Fig 5).
We next tested whether acute or longer term depletion of PIP2/PI(4)P at the PM can affect
channel trafficking. To do this we transiently expressed VSV-E1-Q1, LYN11-FRB and either
PJ-DEAD or PJ in HEK293 cells and recruited the lipid depleting constructs to the PM by add-
ing rapamycin for 1 or 24 hours prior to the start of the assay. In the absence of rapamycin the
expression of PJ-DEAD or PJ did not have an effect (P = NS) on cell-surface or total expression
of the channel (Fig 6). In addition, the application of rapamycin for either 1 or 24 hours, and
therefore induction of PIP2/PI(4)P depletion at the PM, had no effect (P = NS) on cell-surface
or total expression of the channel (Fig 6).
PI(4)P is concentrated in the Golgi and is thought to be important for transport of specific
cargo from the Golgi to the PM [37]. To investigate whether Golgi-localised PI(4)P plays a role
in Q1/E1 trafficking we transiently expressed VSV-E1-Q1, Tgn38-FRB, and either PJ-DEAD
or PJ-SAC in HEK293 cells. In the absence of rapamycin, and therefore Golgi recruitment, the
expression of PJ-DEAD or PJ-SAC did not have an effect (P = NS) on cell-surface or total
expression of the channel (Fig 7). Similarly, the addition of rapamycin, and therefore depletion
of Golgi-localised PI(4)P, for either 1 or 24 hours failed to effect (P = NS) the total or cell-sur-
face expression level of the channel (Fig 7).
Discussion
Differential sensitivity of cardiac ion channels to PIP2
In this study, Q1/E1 channel function was sensitive to the depletion of PIP2. Even in the
absence of rapamycin (the dimerizing agent) the co-expression of PJ and LYN11-FRB dramati-
cally reduced IKs. We reason below that this occurs because of a high sensitivity of the channel
to changes in PM PIP2 levels, which are reduced by the basal constitutive phosphatase activity
of the CID system. The IKs channel β-subunit, KCNE1, confers altered sensitivity to PIP2 [47].
As such, we additionally investigated the regulation of the homomeric KCNQ1 channel. The
loss of this current when expressing PJ and LYN11-FRB, in the absence of rapamycin, also indi-
cates that the homomeric KCNQ1 channel has high sensitivity to PM PIP2 depletion, which
supports the findings of Li and colleagues [47].
For comparison, we investigated the PIP2 regulation of Kir2.1 and Kv11.1 channels (the
pore-forming subunits of the IK1 and IKr currents, respectively) as these are also present in ven-
tricular myocytes and contribute to ventricular repolarisation. In contrast to IKs, the co-expres-
sion of PJ with LYN11-FRB, in the absence of rapamycin, had no effect on either of the
currents. In HEK-IK1 cells, recruitment of PJ to the PM caused a gradual and complete inhibi-
tion of IK1, and in HEK-IKr cells PJ recruitment caused a small (but not significant) reduction
in IKr over the course of the experiment. Thus, Kv11.1/IKr is relatively insensitive to PIP2/PI(4)
P depletion, whilst Kir2.1/IK1 is sensitive. Our findings agree with those reported by Kruse and
colleagues, who showed that Kv11.1 is insensitive to joint depletion of PIP2 and PI(4)P [32].
Prior studies have reported that Kv11.1 is regulated by PIP2, although the effects on channel
function are modest [48, 49]. Recently it has been shown that the co-expression of KCNE2
[32] or the Gq/11-coupled Muscarinic-1 receptor [50] with Kv11.1 confers increased sensitivity
to PIP2. This suggests that the presence of accessory subunits (such as the KCNE family) or Gq/
11-coupled GPCRs, which are expressed in ventricular myocytes, may enhance the PIP2 sensi-
tivity of the IKr channel complex.
The complete loss of IKs even before rapamycin addition indicates that this channel is
extremely sensitive to PIP2 depletion and suggests that the channel complex has a relatively
low apparent affinity for PIP2. In contrast, Kir2.1/IK1 was only significantly inhibited when PJ
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Fig 6. Acute or long-term depletion of PIP2 at the PM does not affect the cell-surface or total expression level of KCNQ1. A and B.
Representative on-cell [37˚C live] and in-cell western assays, enabling quantification of the cell-surface and total channel expression, respectively. The
VSV-E1-Q1 construct was co-expressed in HEK293 cells with pcDNA3.1, or with LYN11-FRB and PJ or PJ-DEAD. Cells expressing LYN11-FRB with
either PJ or PJ-DEAD were incubated in the absence of 5 μM rapamycin (Rap), or in the presence of Rap for 1 hour or 24 hours as indicated. Each
condition was performed in triplicate. Mean data, normalised to VSV-E1-Q1 + pcDNA3.1 values (VSV Control), from three independent experiments
for cell-surface and total channel expression are shown in C and D, respectively. Data presented as mean ± S.E.M. * indicates significant difference (P
<0.05) from control (VSV-E1-Q1 + pcDNA3.1) values.
https://doi.org/10.1371/journal.pone.0186293.g006
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Fig 7. Depletion of PI(4)P at the Golgi does not affect the cell-surface or total expression level of KCNQ1. A and B. Representative on-cell [4˚C
fixed] and in-cell western assays, enabling quantification of the cell-surface and total cellular expression, respectively. The VSV-E1-Q1 construct was
co-expressed in HEK293 cells with pcDNA3.1, or with Tgn38-FRB and PJ-SAC or PJ-DEAD. Cells expressing Tgn38-FRB with either PJ-SAC or
PJ-DEAD were incubated in the absence of 5 μM rapamycin (Rap), or in the presence of Rap for 1 hour or 24 hours as indicated. Each condition was
performed in triplicate. Mean data, normalised to VSV-E1-Q1 + pcDNA3.1 values (VSV Control), from three independent experiments for cell-surface
and total channel expression are shown in C and D, respectively. Data presented as mean ± S.E.M. * indicates significant difference (P <0.05) from
control (VSV-E1-Q1 + pcDNA3.1) values.
https://doi.org/10.1371/journal.pone.0186293.g007
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was recruited to the PM and both PIP2 and PI(4)P were depleted. The inability of PJ-INPP5E
recruitment to inhibit Kir2.1/IK1 could have been because the level of PIP2 depletion achieved
was not high enough to inhibit channel function, or alternatively it could be because PI(4)P is
equally able to activate the channel in the absence of PIP2 (especially since PJ-INPP5E converts
PIP2 to PI(4)P). A recent study directly addressed this question and found that the application
of PI(4)P, in giant excised patches, does not activate Kir2.1 [51]. Therefore, we feel that the dif-
ferences in the ability of PJ and PJ-INPP5E to inhibit Kir2.1/IK1 directly reflect how strongly
they can deplete PIP2. In comparison to IKs, the inhibition of Kir2.1/IK1 channel activity
requires a greater reduction in PIP2. This implies that Kir2.1 has a higher relative apparent
affinity for PIP2. To our knowledge the relative affinities of Q1/E1 and Kir2.1 for PIP2 have not
been directly compared (in the same study). However, Kir2.1 has been postulated to have an
approximately seventeen-fold higher affinity than KCNQ2 for PIP2 [32]. Based on our findings
we speculate that the activity of IKs, but not IK1 or IKr, is likely to be strongly affected by even
small fluctuations in the levels of PIP2. This is similar to our previous observations regarding
the PIP2 sensitivity of ATP-sensitive potassium channels [52], and is consistent with the find-
ings by Kruse and colleagues that only a specific subset of ion channels are highly sensitive to
PIP2 depletion [32, 53].
Drawbacks of the CID system
Manipulation of cellular PIP2 levels using methods such as excised-patch recordings [16], Gq/
11-coupled receptor activation [54] and exogenous application of PIP2 analogues [25] give
insights into the dependence of the Q1/E1 channel on PIP2 for function. However, what these
experimental methods do not allow is a direct, isolated and specific manipulation of PIP2 levels
within the cell. In theory, the CID system should overcome these issues, and it has indeed been
used to investigate a range of ion channels including the Q1/E1 channel and other members of
the KCNQ family [32]. However, when we expressed PJ or PJ-INPP5E with LYN11-FRB, inhi-
bition of IKs occurred even before rapamycin was added.
Could a low level of lipid depletion at the PM occur by expressing active lipid-depleting
constructs, even in the absence of rapamycin? The phosphatase domains of the lipid-depleting
constructs are constitutively active, which could confer a low level of cellular PIP2 depletion
(and/or PI(4)P in the case of PJ and PJ-SAC, respectively). In our imaging experiments it is
clear that the lipid-depleting constructs are expressed throughout the cytosol. The cytosolic
expression of the phosphatase constructs could allow a low level of lipid depletion by con-
structs that are coincidentally close to the PM, as has been discussed previously [35]. Even
without LYN11-FRB, the expression of PJ in HEK-IKs cells caused a 50% reduction of current.
Interestingly, the fact that LYN11-FRB expression confers increased inhibition of IKs indi-
cates that there may be a low level interaction between these two constructs, possibly between
the FRB and FKBP domains in the absence of rapamycin. A 2.2 Angstrom resolution structure
of the FRB-rapamycin-FKBP complex showed multiple residues involved in the protein-pro-
tein interaction [55]. A transient and weak interaction could somewhat concentrate the lipid-
depleting constructs at the PM. Overall, our findings highlight that the constitutive phospha-
tase activity of the CID system is an inherent problem when trying to study highly sensitive
PIP2 effectors, such as the Q1/E1 channel.
PIP2 and PI(4)P do not regulate the cell-surface expression level of Q1/
E1
The observation that the CID system was not optimal for investigation of Q1/E1 channel func-
tion does not preclude using it to study the role of PIP2 and other anionic phospholipids in
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channel trafficking. To calibrate the in-cell and on-cell western assays a number of positive
control experiments were performed. These were known to affect broad trafficking pathways
or specifically channel surface expression. The expression of the SAR1 mutant, SAR1-H79G,
and the KCNQ1 dominant negative (DN) mutant, KCNQ1-E2691D, both caused a reduction
in the cell-surface expression of the VSV-E1-Q1 construct whilst preserving total channel
expression. SAR1-H79G has a DN effect over WT SAR1 and prevents vesicle trafficking
between the ER and Golgi [42], explaining the reduction in VSV-E1-Q1 cell-surface expres-
sion. KCNQ1-E261D is retained in the ER and has a DN effect over the trafficking of the WT
channel [26, 56]. These cellular manipulations indicate that the in-cell/on-cell western assays
can faithfully report changes in channel trafficking to the PM.
To find out if acute or long-term depletion of PIP2 and/or PI(4)P at the PM affected traf-
ficking of the Q1/E1 channel, cells expressing the lipid-depleting constructs were incubated
with or without rapamycin for 1 hour or 24 hours. None of these conditions resulted in any
changes in the cell-surface or total expression of the channel, suggesting that the reduction
of PIP2 and/or PI(4)P at the PM does not affect trafficking or expression. PI(4)P is present at
the Golgi in higher concentrations than the rest of the cell, and is suggested to be involved in
the anterograde trafficking of proteins destined for the PM. Thus, we depleted PI(4)P at the
Golgi using PJ-SAC expressed with Tgn38-FRB [37, 57]. We found that there was no change
in channel cell-surface or total expression when PJ-SAC was recruited to the Golgi with
either 1 or 24 hour rapamycin incubation, despite Golgi recruitment of CID constructs
(S4 Fig).
In contrast, wortmannin incubation (for 1 hour) reduced the cell-surface expression of
VSV-E1-Q1 (by ~50%) without altering total channel expression. Given that the depletion of
PIP2 and/or PI(4)P (upon recruitment of PJ to the PM and PJ-Sac to the Golgi) did not alter
Q1/E1 trafficking we feel that it is unlikely that the effects of wortmannin are mediated
through PI4K inhibition. At both high and low concentrations wortmannin is a potent inhibi-
tor of PI3Ks [58]. PI3Ks control the production of a number of phosphoinositides including
phosphatidylinositol-3-phosphate (PI(3)P), phosphatidylinositol-3,4-bisphosphate (PI(3,4)P2)
and phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P3) [59]. Wortmannin-mediated dis-
ruption of PI3K activity could therefore lead to reduced levels of these phosphoinositides. PI
(3)P is highly concentrated on early endosomes and is involved in the recycling of membrane
proteins [13], which may explain why the trafficking of the channel is perturbed. Additionally,
the reduction of PI(3)P could also lead to reduced levels of phosphatidylinositol-3,5-bispho-
sphate (PI(3,5)P2). Intriguingly, an enhanced production of PI(3,5)P2 has been suggested to be
central in mediating an increased rate of Q1/E1 channel exocytosis upon activation of the
serum and glucocorticoid-inducible kinase 1 [60].
Our findings suggest that the increased degree of channel retention in the ER seen upon
charge neutralisation of residues in a PIP2 binding site (Fig 1) is not due to perturbed binding
to PIP2 and or PI(4)P. It is possible that the increases seen in ER channel retention are solely
due to non-specific effects of these mutations on protein stability/folding. However, the inhibi-
tory effects of wortmannin on Q1/E1 trafficking highlight that other phosphoinositides, such
as PI(3)P and PI(3,5)P2, could play a role and this warrants future investigation.
In conclusion, we identify that the Q1/E1 channel does not require PIP2 and/or PI(4)P for
anterograde trafficking, but is heavily reliant on PIP2 for function once at the PM. It has been
postulated that the relatively low level of PIP2 in the secretory pathway is important for silenc-
ing (or activating) specific ion channels whilst in transit [11, 61]. For Q1/E1, our findings sup-
port this hypothesis and it is likely that the channel becomes activated by PIP2 once it reaches
the PM.
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Supporting information
S1 Fig. The effect of expressing lipid-depleting constructs on IK1 and IKr. A. Representative
traces of currents recorded from HEK-IK1 cells (control), and HEK-IK1 cells transiently
expressing PJ-DEAD, PJ-INPP5E or PJ with LYN11-FRB. B. Mean CD of currents recorded
from untransfected HEK-IK1 cells (control; n = 11) and HEK-IK1 cells transiently expressing PJ
(n = 9), PJ-INPP5E (n = 11) or PJ-DEAD (n = 9) with LYN11-FRB. C. Representative traces of
currents recorded from HEK-IKr cells (control), and HEK-IKr cells transiently expressing
PJ-DEAD or PJ with LYN11-FRB. D. Mean PTCD of currents recorded from HEK-IKr cells
(control; n = 9) and HEK-IKr cells transiently expressing PJ (n = 10) or PJ-DEAD (n = 10) with
LYN11-FRB. Data are presented as mean ± S.E.M.
(TIF)
S2 Fig. The effect of expressing lipid-depleting constructs in CHO-K1 cells expressing IKs.
A. Representative traces of currents recorded from CHO-K1 cells transiently expressing the
KCNQ1 and KCNE1 subunits with LYN11-FRB and either PJ-DEAD or PJ. B. Voltage proto-
col used to elicit current recorded. C. Mean CD (top) and PTCD (bottom) of currents from
CHO-K1 cells transiently expressing KCNQ1 and KCNE1 with LYN11-FRB and either
PJ-DEAD (n = 12) or PJ (n = 11). Data are presented as mean ± S.E.M. An unpaired t-test was
performed to determine statistical significance between groups in C, at voltages between +30
mV and +80 mV.  indicates significant difference (P<0.05) from control (KCNQ1 + KCNE1
+ PJ-DEAD) value.
(TIF)
S3 Fig. The effect of expressing lipid-depleting constructs in CHO-K1 cells expressing the
homomeric KCNQ1 channel. A. Representative traces of currents recorded from CHO-K1
cells transiently expressing KCNQ1 with LYN11-FRB and either PJ-DEAD or PJ. B. Voltage
protocol used to elicit current recorded. C. Mean CD (top) and PTCD (bottom) of currents
from CHO-K1 cells transiently expressing KCNQ1 with LYN11-FRB and either PJ-DEAD
(n = 11) or PJ (n = 10). Data are presented as mean ± S.E.M. An unpaired t-test was performed
to determine statistical significance between groups in C, at voltages between +30 mV and +80
mV.  indicates significant difference (P<0.05) from control (KCNQ1 + PJ-DEAD) value.
(TIF)
S4 Fig. The rapamycin-induced recruitment of PJ to the Golgi. Top panel: The localisation
of PJ and Tgn38-FRB in HEK293 cells. The five centre and bottom rows show the same cell at
different time points after the addition of rapamycin (5 μM). Scale bar indicates 20 μm.
(TIF)
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